| Variable | Total (N = 63) | OV Group (N = 30) | Placebo Group (N = 33) | p |
| Age |
|
|
|
|
| Mean (SD) | 59.3 (12.2) | 58.5 (13.2) | 60.1 (11.4) | 0.611 |
| Range | 33 - 81 | 34 - 78 | 33 - 81 |
|
| Histological diagnostics |
|
|
|
|
| Epidermoid carcinoma of the cervix | 38 (60.3) | 14 (46.7) | 24 (72.7) | <0.001a |
| Endocervical adenocarcinoma | 5 (8.0) | 0 (0.0) | 5 (15.2) | |
| Endometrial adenocarcinoma | 20 (31.7) | 16 (53.3) | 4 (12.1) | |
| Clinical stage |
|
|
|
|
| Ib | 2 (3.2) | 2 (6.7) | 0 (0.0) | 0.485b |
| Ic | 5 (7.9) | 4 (13.3) | 1 (3.0) | |
| IIa | 3 (4.8) | 2 (6.7) | 1 (3.0) | |
| IIb | 35 (55.5) | 15 (50.0) | 20 (60.6) | |
| IIIa | 7 (11.1) | 5 (16.7) | 2 (6.1) | |
| IIIb | 10 (15.9) | 2 (6.6) | 8 (24.2) | |
| IV | 1 (1.6) | 0 (0.0) | 1 (3.0) | |
| Personal medical history |
|
|
|
|
| Health | 22 (34.9) | 9 (30.0) | 13 (39.4) | 0.533 |
| Concurrent diseases | 41 (65.1) | 21 (70.0) | 20 (60.6) | |
| Including: |
|
|
|
|
| HBP | 37 (58.7) | 20 (31.7) | 17 (27.0) | 0.165 |
| Diabetes mellitus | 11 (17.5) | 8 (12.7) | 3 (4.8) | 0.655 |
| Bronchial asthma | 4 | 3 | 1 |
|
| Endocrine system disorders | 3 | 1 | 2 |
|
| Ischemic cardiopathy | 3 | 1 | 2 |
|
| Obesity | 3 | 1 | 2 |
|
| ECOG (performance status) |
|
|
|
|
| Grade 0 | 39 (61.9) | 17 (56.7) | 22 (66.7) | 0.325c |
| Grade 1 | 14 (22.2) | 8 (26.7) | 6 (18.2) | |
| Grade 2 | 9 (14.2) | 5 (16.6) | 4 (12.1) | |
| Grade 3 | 1 (1.7) | 0 (0.0) | 1 (3.0) |